Symptoms are dyspnea, pain and reduced common feeling. Aine of the study wa
s, to compare our results of talc pleurodesis with the literature. In a pro
spective trial we performed talc pleurodesis via a chest tube in 41 patient
s. All patients had radiologically proven pleural effusions. No additional
therapy was permitted 30 days before or after entry into the study. Respons
e was assessed monthly. Seven patients dies because of tumor progress. We e
xamined 34 patients. Treatment was successful in 31 patients adverse effect
s we saw only a few times. Application of iodized talc for therapy of malig
nant pleural effusions is effective and cheep. We did not see major adverse
effects or complications.